Abaxis, Inc.
United States

Abaxis, Inc. produces and markets point-of-care blood analyzers, which provide clinicians with rapid measurement of blood-constituents for both humans and animals.

The analyzers are designed to be portable, require minimal training, provide on-the-spot results, and offer built-in quality control and calibration. The analyzers utilize disposable reagent discs to perform several of the most common blood tests, all approved by the FDA.

Abaxis, Inc. shares are publicly traded on NASDAQ (NASDAQ:ABAX).

Status: Realised